Yes, genetic markers can significantly influence prognosis. For example, in cystic fibrosis, certain genetic mutations are associated with more severe disease and poorer outcomes. In neuroblastoma, the presence of MYCN amplification is a poor prognostic marker, associated with aggressive disease.
